Herman Waldmann

发表

CAMPATH-1H in multiple sclerosis

A. Compston, A. Coles, G. Hale, 1996, Multiple sclerosis.

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?

S. Mackinnon, G. Hale, H. Waldmann, 2002, Bone Marrow Transplantation.

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

H. Waldmann, S. Cobbold, S. Qin, 1986, Nature.

CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules.

T. Hoang, H. Waldmann, F. Grunert, 1991, Blood.

Therapeutic approaches for transplantation.

H. Waldmann, Herman Waldmann, 2001, Current opinion in immunology.

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.

G. Hale, H. Waldmann, C. Bindon, 1985, Advances in experimental medicine and biology.

Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trial.

S. Gore, P. Friend, G. Hale, 1989, Transplantation.

Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.

G. Hale, H. Waldmann, J. Cornish, 1999, Blood.

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

M. Dyer, R. Marcus, G. Hale, 1990, Leukemia & lymphoma.

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.

G. Hale, H. Waldmann, D. Metcalf, 1983, Blood.

Mechanisms of antibody immunotherapy on clonal islet reactive T cells.

D. Roelen, J. Medema, G. Hale, 2006, Human immunology.

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.

D. Bunjes, Mei-Jie Zhang, M. Horowitz, 1998, Blood.

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation

S. Mackinnon, H. Waldmann, D. Linch, 2001, Bone Marrow Transplantation.

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.

G. Hale, H. Waldmann, Geoff Hale, 1994, Journal of hematotherapy.

Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression.

H. Waldmann, S. Cobbold, Y. Kong, 1989, Clinical immunology and immunopathology.

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.

G. Hale, H. Waldmann, Geoff Hale, 1998, Blood.